Aspiration Pneumonia

Back

Overview of Aspiration Pneumonia

Aspiration is defined as the inhalation of either oropharyngeal or gastric contents into the lower airways; that is, the act of taking foreign material into the lungs. This can cause a number of syndromes determined by the quantity and nature of the aspirated material, the frequency of aspiration, and the host factors that predispose the patient to aspiration and modify the response.[1]

Three types of material cause 3 different pneumonic syndromes. Aspiration of gastric acid causes chemical pneumonia, which has also been called aspiration pneumonitis (Mendelson's syndrome)—although the former is an infectious process and the latter is a chemical injury, and both are managed differently.[1] Aspiration of bacteria from oral and pharyngeal areas causes bacterial pneumonia, and aspiration of oil (eg, mineral oil or vegetable oil) causes exogenous lipoid pneumonia, a rare form of pneumonia. In addition, aspiration of a foreign body may cause an acute respiratory emergency and, in some cases, may predispose the patient to bacterial pneumonia.

Aspiration pneumonia, according to common usage, includes both chemical and bacterial pneumonia, although the pathophysiology, clinical presentation, treatment, and complications of each entity are different.[2]

For patient education information, see eMedicineHealth's Pneumonia Center, as well as Chemical Pneumonia, Bacterial Pneumonia and Bronchoscopy.

For more information, see the following:

The images below depict aspiration pneumonia in 2 different patients.


View Image

Aspiration pneumonia in an 84-year-old man in generally good health who had fever and cough. This posteroanterior radiograph demonstrates a left lower....


View Image

Chest radiograph of a patient with aspiration pneumonia of the left lung after a benzodiazepine overdose. The patient was probably positioned to the l....

Predisposing Conditions for Aspiration Pneumonia

Almost all patients who develop aspiration pneumonia have one or more of the predisposing conditions listed below. Although all the listed conditions predispose the patient to chemical pneumonia, conditions that alter consciousness and periodontal disease specifically predispose the patient to bacterial pneumonia.

Conditions associated with altered or reduced consciousness, including any condition that reduces a patient's gag reflex, ability to maintain an airway, or both, increases the risk of aspiration pneumonia or pneumonitis. Such conditions are as follows:

Esophageal conditions associated with aspiration pneumonia include the following:

Neurologic disorders also predispose to aspiration pneumonia, such as the following:

Aspiration pneumonia is also associated with the following mechanical conditions:

Other types of associated conditions are as follows:

Pathophysiology of Aspiration Pneumonia

In aspiration pneumonia, an infiltrate develops in a patient at increased risk of oropharyngeal aspiration. This occurs when a patient inhales material from the oropharynx that is colonized by upper airway flora.

The risk of aspiration is indirectly related to the level of consciousness of the patient (ie, decreasing Glasgow Coma Scale [GCS; see the Glasgow Coma Scale calculator] score is related with increased risk of aspiration).[4] Aspiration of small amounts of material from the buccal cavity, particularly during sleep, is not an uncommon event. No disease ensues in healthy persons, because the aspirated material is cleared by mucociliary action and alveolar macrophages. The nature of the aspirated material, volume of the aspirated material, and state of the host defenses are 3 important determinants of the extent and severity of aspiration pneumonia.

Chemical pneumonia

Chemical pneumonia, also known as aspiration pneumonitis and Mendelson syndrome, is due to the parenchymal inflammatory reaction caused by a large volume of gastric contents independent of infection. In fact, aspiration of a massive amount of gastric contents can produce acute respiratory distress within 1 hour. This disease occurs in people with altered levels of consciousness resulting from seizures, cerebrovascular accident (CVA), central nervous system (CNS) mass lesions, drug intoxication or overdose, and head trauma.

The acidity of gastric contents results in chemical burns to the tracheobronchial tree involved in the aspiration. If the pH of the aspirated fluid is less than 2.5 and the volume of aspirate is greater than 0.3 mL/kg of body weight (20-25 mL in adults), it has a greater potential for causing chemical pneumonia. The initial chemical burn is followed by an inflammatory cellular reaction fueled by the release of potent cytokines, particularly tumor necrosis factor (TNF)–alpha and interleukin (IL)–8.

Bacterial pneumonia

Bacterial pneumonia most commonly occurs in individuals with chronically impaired airway defense mechanisms, such as gag reflex, coughing, ciliary movement, and immune mechanisms, all of which aid in removing infectious material from the lower airways. This syndrome caused by aspiration can occur in the community or in the hospital (ie, nosocomial). In both situations, anaerobic organisms alone or in combination with aerobic and/or microaerophilic organisms play a role. In anaerobic pneumonia, the pathogenesis is related to the large volume of aspirated anaerobes (eg, as in persons with poor dentition, poor oral care, and periodontal disease) and to host factors (eg, as in alcoholism) that suppress cough, mucociliary clearance, and phagocytic efficiency, both of which increase the bacterial burden of oropharyngeal secretions.

Nosocomial bacterial pneumonia caused by aspiration is common, and the major pathogens involved are hospital-acquired florae through oropharyngeal colonization (eg, enteric gram-negative bacteria, staphylococci). Selection and colonization of gram-negative organisms in the oropharynx, sedation, and intubation of the patient's airways are important pathogenetic factors in nosocomial pneumonia.

Because of the relative sterility of normal gastric contents, bacteria do not play an important role in the early stages of the disease. This does not hold true in patients with gastroparesis or small-bowel obstruction or in those using antacids (proton pump inhibitors [PPIs], H2-receptor antagonists). Regardless of the bacterial load of the inoculum, bacterial superinfection may occur after the initial chemical injury.

Causative microorganisms

Initial bacteriologic studies into the causative organisms revealed the anaerobic species to be the predominant pathogens in community-acquired aspiration pneumonia. However, subsequent studies revealed that Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Enterobacteriaceae are the most common organisms.[1] In fact, in 2 studies of patients with acute, witnessed aspiration with protective specimen brush sampling and anaerobic culturing, no anaerobes were isolated.[5, 6] However, hospital-acquired aspiration pneumonia is often caused by gram-negative organisms including Pseudomonas aeruginosa, particularly in intubated patients.[7]

Additionally, methicillin-resistant S aureus (MRSA) was more commonly found (4.2% vs 1.4%) in those with healthcare-associated versus community-acquired aspiration pneumonia.[8] These studies demonstrated a limited role of anaerobic pathogens in both the community and nosocomial variants of the disease.

Epidemiology of Aspiration Pneumonia

A reliable estimate of incidence of chemical pneumonia is not available. Few studies have been designed that distinguish between aspiration pneumonia and aspiration pneumonitis. Several studies suggest that 5-15% of the 4.5 million cases of community-acquired pneumonia (CAP) result from aspiration pneumonia.[1] A retrospective review found that the 30-day mortality rate from aspiration pneumonia is 21% overall and slightly higher in healthcare-associated aspiration pneumonia (29.7%).[8]

Nosocomial bacterial pneumonia is the second most likely cause of nosocomial infections, second only to urinary tract infection, and it is the leading cause of death from hospital-acquired infections. Approximately 10% of patients who are hospitalized after drug overdoses will have an aspiration pneumonitis.

Nosocomial bacterial pneumonia caused by aspiration is much more frequent in adults than in children, and males are more commonly affected than females. Predisposing factors (see Predisposing Conditions for Aspiration Pneumonia)are more common among elderly people; therefore, this population is more prone to develop aspiration pneumonia.[9] Comparative studies of bacterial pneumonia in patients from the community with those in a continuing care facility have shown a 3-fold increase of this disease in residents of the continuing care facilities (the majority of them had neurologic disease with dysphagia).[10]

Presentation of Aspiration Pneumonia

The clinical presentation of both aspiration pneumonia and pneumonitis ranges from mildly ill and ambulating to critically ill, with signs and symptoms of septic shock and/or respiratory failure.

Host factors and chronic conditions that result in a decreased ability to protect one's airway include a previous cerebrovascular accident (CVA), a history of esophageal diseases including achalasia[11] or esophageal web, being a nursing home patient, and being chronically fed by feeding tube (nasogastric [NG] tube or gastric tube).

Physical examination findings vary depending on the severity of the disease, presence of complications, and host factors. Patients with aspiration pneumonitis secondary to seizure, head trauma, or drug overdose should be inspected for signs related to these processes. In addition to exhibiting signs associated with the underlying disease that led to their aspiration, patients with aspiration pneumonia or pneumonitis may demonstrate the following:

Chemical pneumonia

Patients with chemical pneumonia may present with an acute onset or abrupt development of symptoms within a few minutes to 2 hours of the aspiration event, as well as respiratory distress and rapid breathing, audible wheezing, and cough with pink or frothy sputum.

Findings on physical examination may include tachypnea, tachycardia, fever, rales, wheezing, and possibly cyanosis.

Bacterial pneumonia

The presentation of bacterial aspiration pneumonia is similar to that of community-acquired pneumonia (CAP) and may include nonspecific symptoms including headache, nausea/vomiting, anorexia, weight loss. The onset of illness may be subacute or insidious, with the symptoms manifesting in days to weeks when anaerobic organisms are the pathogens. The patient may also describe the following:

In hospital acquired aspiration pneumonia, the symptoms of cough and shortness of breath of may be more acute in onset than in CAP when aerobic organisms are the pathogens; fever and rigors may be present.

Patients brought in after witnessed large-volume vomitus and subsequent aspiration pneumonitis will have a history consistent with an acute change in mental status, which may include seizure, alcohol abuse, drug overdose, and/or head trauma.

On physical examination, findings may include periodontal disease (primarily noted as gingivitis), bad breath, fever, bronchial breath sounds and rales over a consolidated posterior area, and possibly clubbing of the fingers.

Diagnosis in Aspiration Pneumonia

Clinicians must consider the diagnosis of aspiration pneumonia when a patient presents with risk factors and radiographic evidence of an infiltrate suggestive of aspiration pneumonia (see Predisposing Conditions for Aspiration Pneumonia). The location of the infiltrate on chest radiograph depends on the position of the patient when the aspiration occurred.

The laboratory studies obtained should be guided by the patient’s clinical presentation (see Presentation of Aspiration Pneumonia). Patients with signs or symptoms of sepsis or septic shock require further laboratory testing than those with uncomplicated aspiration syndromes.

Differentials

When evaluating a patient with suspected aspiration pneumonia, also consider necrotizing pneumonia, bronchopleural fistula, lung carcinoma, lung abscess, mycoses, and hypersensitivity pneumonitis. In children, consider bronchiolitis, croup or laryngotracheobronchitis, epiglottitis, asthma, reactive airway disease, respiratory distress syndrome, and foreign bodies. In addition, assess for the following conditions:

Arterial Blood Gas and Mixed Venous Gas Analysis

Arterial blood gas (ABG) analysis is used to assess oxygenation and pH status and adds information to guiding oxygen supplementation. The results demonstrate acute hypoxemia in patients with chemical pneumonia and normal to low partial pressure of carbon dioxide with respiratory alkalosis. The lactate level (often included with blood gases) can be used as an early marker of severe sepsis or septic shock.

A mixed venous gas measurement should be obtained in any patient in whom septic shock is suspected. Decreased mixed venous oxygen saturation is a marker for septic shock.

Basic Metabolic Panel

Serum electrolyte, blood urea nitrogen (BUN), and creatinine levels can be used to assess fluid status and the need for intravenous hydration. This is especially important in patients who present with fever, vomiting, or diarrhea who may have significant fluid loss.

Serum BUN and creatinine levels can also be used to assess renal function in order to appropriately dose antibiotics. In addition, these values can be used to assess end-organ damage in patients who present with sepsis or septic shock.

CBC With Differential

The complete blood cell (CBC) count may reveal an elevated white blood cell (WBC) count, increased neutrophils, anemia, and thrombocytosis in patients with bacterial pneumonia caused by anaerobic bacteria. Elevated WBC count and increased neutrophils may also be present in patients with chemical pneumonia.

Sputum Gram Stain, Microscopy, and Culture

Although sputum culture and Gram stain are generally not helpful in the initial diagnosis or treatment, sputum Gram stain and microscopy reveal a multitude of bacteria (eg, cocci, bacilli, coccobacillary forms, spirochetes, fusiforms) in patients with bacterial pneumonia caused by anaerobic bacteria. In nosocomial bacterial pneumonia, sputum culture may be helpful in detecting gram-negative bacteria.

Findings on sputum culture may not isolate organisms, because the major pathogens are anaerobes.

Blood Cultures

Use blood cultures as a baseline screening for bacteremia. In uncomplicated pneumonia (no signs of sepsis or septic shock), blood cultures have a low yield and are not necessary for the initial management and treatment.

Chest Radiography

Radiographic evidence of aspiration pneumonia depends on the position of the patient when the aspiration occurred.[12] The right middle and lower lung lobes are the most common sites of infiltrate formation due to the larger caliber and more vertical orientation of the right mainstem bronchus.[12] Patients who aspirate while standing can have bilateral lower lung lobe infiltrates. Patients lying in the left lateral decubitus position are more likely to have left-sided infiltrates (see the following image). The right upper lobe is a common area of consolidation in alcoholics who aspirate in the prone position.


View Image

Chest radiograph of a patient with aspiration pneumonia of the left lung after a benzodiazepine overdose. The patient was probably positioned to the l....

The presence of pleural effusion may indicate the need to perform thoracentesis to rule out empyema.

Chemical pneumonia

Chest radiographic findings in patients with chemical pneumonia are characterized by the presence of infiltrates, predominantly the alveolar type, in one or both lower lobes, or diffuse simulation of the appearance of pulmonary edema. Volume loss in any lobar area suggests obstruction (eg, by aspirated food particles or other foreign bodies) in the bronchus.

Bacterial pneumonia

Chest radiographic findings in patients with anaerobic bacterial pneumonia typically demonstrate an infiltrate with or without cavitation in one of the dependent segments of the lungs (ie, posterior segments of the upper lobes, superior segments of the lower lobes). Lucency within the infiltrate suggests a necrotizing pneumonia. Air-fluid levels within a circumscribed infiltrate (density) indicate a lung abscess or a bronchopleural fistula. Costophrenic angle blunting and the presence of a meniscus are signs of a parapneumonic pleural effusion.

More images in patients with aspiration pneumonia are provided below.


View Image

Aspiration pneumonia in an 84-year-old man in generally good health who had fever and cough. This posteroanterior radiograph demonstrates a left lower....


View Image

Lateral radiograph in an 84-year-old patient with aspiration pneumonia confirms the location of the abnormality in the left lower lobe.


View Image

Chest radiograph of a patient with massive aspiration pneumonia of the right lung.

Ultrasonography

Ultrasonography is helpful when confirming and locating pleural effusions.

CT Scanning

Computed tomography (CT) scan of the chest is not needed in all cases of suspected aspiration pneumonia. This imaging modality may be helpful in further characterizing pleural effusions or empyema, such detecting necrosis within infiltrates, cavities, and loculated pleural effusions. CT scanning provides a better definition of the affected areas and is used to differentiate pulmonary abnormalities from pleural abnormalities.

Bronchoscopy

Bronchoscopy is indicated in patients with chemical pneumonia only when aspiration of a foreign body or food material is suspected. Bronchoscopy with protected brush and a protected catheter are used to retrieve pathogens in bacterial pneumonia and may be helpful in guiding antibiotic therapy. This procedure is useful when ruling out the presence of an obstructing neoplasm in anaerobic bacterial pneumonia with lung abscess; however, bronchoscopy is not useful in the treatment of community-acquired aspiration pneumonia.

Pulmonary Artery Catheterization

Pulmonary artery catheter placement may be needed to differentiate cardiac from noncardiac pulmonary edema caused by chemical pneumonia and for appropriate fluid management.

Thoracentesis

Thoracentesis, also known as pleural fluid aspiration, is a diagnostic and therapeutic procedure in which fluid (or air) is removed from between the pleura and chest wall. Analysis of the specimen can help determine the underlying cause of the pleural effusion as well as relieve any symptoms from excess build up of fluid. A chest x-ray should be obtained both before and after this procedure to detect possible complications from the thoracentesis.

Mechanical Ventilation

Mechanical ventilation is needed in severe cases of chemical pneumonia that cause acute respiratory distress syndrome (ARDS).

Chest Tube Placement

Placement of a chest tube can be used to drain large empyema.

Prehospital Management of Aspiration Pneumonia

Prehospital care should focus on stabilizing the patient's airway, breathing, and circulation. In patients found with signs of gastric aspiration (ie, vomitus) suctioning of the upper airway may remove a significant amount of aspirate or potential aspirate.

Intubation should be considered in any patient who is unable to protect his or her airway. The ability of paramedics to provide this intervention depends on the level of their training.[13] In addition, emergency medical technicians (EMTs) trained in intubation may choose to intubate patients with poor gag reflex before aspiration.

Other measures include the following:

Emergency Department Management

Emergency department care should start with stabilizing the patient's airway, breathing, and circulation. Oropharyngeal/tracheal suctioning may be indicated to further remove aspirate.

Reassess the need for intubation on a frequent basis depending on the patient’s oxygenation, the patient's mental status, signs of increased work of breathing, or impending respiratory failure.

Continue supplemental oxygenation as needed, as well as continue cardiac monitoring and pulse oximetry and provide continued supportive care with intravenous fluids and electrolyte replacement.

Inpatient Management

Patients with aspiration pneumonia, both chemical pneumonia (chemical pneumonia) and bacterial pneumonia (bacterial pneumonia), need inpatient care for several reasons, including the acuity of illness, host factors, and the uncertain course and prognosis of aspiration pneumonia.[14]

Admit patients with severe hemodynamic compromise and/or persistent respiratory distress to the intensive care unit (ICU). Intubated and ventilated patients must be transferred to a hospital with an ICU, as well as patients with signs or symptoms indicating severe sepsis or septic shock.

If the patient's respiratory status is stabilized, admit the patient to a general-care floor.

Complications

Complications of chemical pneumonia include acute respiratory failure, acute respiratory distress syndrome (ARDS),[15] and nosocomial bacterial pneumonia. Complications of bacterial pneumonia include parapneumonic effusion, empyema, lung abscess, and superinfection; bronchopleural fistula is also a complication.

Aspiration pneumonitis can rapidly progress to respiratory failure.

Consultations

Consultation with the following specialists may be warranted:

Overview of Antimicrobial Therapy

Antibiotics are always indicated for aspiration pneumonia; however, for aspiration pneumonitis, early presumptive antibiotics (ie, prophylactic) are not recommended. This practice is believed to lead to the selection of more resistant organisms.[18] In addition, those patients with recent aspiration, fever, and leukocytosis should not be treated even in the presence of a pulmonary infiltrate due to the risk of development of resistant organisms. The following situations call for the use of antibiotics in managing pneumonitis:

Antibiotic choice

In patients without a toxic appearance, the antibiotic chosen should cover typical community-acquired pathogens. Ceftriaxone plus azithromycin, levofloxacin, or moxifloxacin are appropriate choices.

In patients with a toxic appearance or who were recently hospitalized, although community-acquired pathogens are still the most common, gram-negative bacteria including Pseudomonas aeruginosa and Klebsiella pneumoniae as well as methicillin-resistant Staphylococcus aureus (MRSA) must be covered. Piperacillin/tazobactam or imipenem/cilastatin plus vancomycin would be appropriate. Telavancin is indicated for hospital-acquired pneumonia, including ventilator-associated bacterial pneumonia caused by susceptible isolates of Staphylococcus aureus, including methicillin-susceptible and resistant isolates, when alternative treatments are not suitable. The presence of chronic aspiration risks, putriddischarge, indolent hospital course, and necrotizing pneumonia should raise the suspicion for anaerobic bacteria involvement and prompt consideration of adding clindamycin to the antibiotic regimen.[19]

Treatment of individuals with chemical pneumonia should include maintenance of the airways and clearance of secretions with tracheal suctioning, oxygen supplementation, mechanical ventilation if the patient is unable to maintain adequate oxygenation, early use of positive end-expiratory pressure (PEEP), and administration of intravenous (IV) fluids. Routine use of corticosteroids is not recommended, because supporting studies, both animal and human, are not convincing of a favorable benefit-to-risk ratio.

Early prophylactic (before evidence of a bacterial pneumonia) use of antibiotics, although widely practiced, is not backed by evidence. Choosing antibiotics based on organisms cultured from sputum, tracheal aspirates, or aspirate obtained through a protected catheter by bronchoscopy rather than empirically is more appropriate. However, because the chemically injured bronchi and lungs are very susceptible to bacterial infection, it is reasonable to use antimicrobial agents based on the probability of the bacteria, the severity of the pneumonia, patient-related risk factors (eg, malnutrition, comorbid illnesses), intervention-related factors (eg, previous use of antibiotics, corticosteroids, cytotoxic agents, endotracheal tube), and the duration of hospitalization.

Initial treatment in patients with suspected aspiration pneumonia without risk factors for anaerobic involvement should mirror the treatment of community-acquired pneumonia: a third-generation cephalosporin with a macrolide or a fluoroquinolone alone. However, in severe pneumonia occurring many days after initiation of mechanical ventilation, the probability of resistant organisms, including Pseudomonas aeruginosa, Acinetobacter species, and methicillin-resistant S aureus (MRSA), is increased, and, therefore, antibiotic treatment should be broader.

One study in a respiratory ICU of aspiration pneumonia found that patients were more likely to have gram-negative bacilli (57.8%), fungal infections (28.9%), and gram-positive cocci (13.3%); antibiotic resistance was common.[20] The choices of antimicrobial agents include respiratory fluoroquinolones, aminoglycoside with antipseudomonal penicillin, fourth-generation cephalosporins, imipenem, and vancomycin.

Corticosteroid Management

Historically corticosteroids have been used in the treatment of aspiration pneumonitis, but randomized control studies have been unable to demonstrate a benefit to using high-dose corticosteroids.

The physician should consider the use of stress-dose steroids in patients with septic shock that requires vasoactive substances to maintain blood pressure and in those on long-term steroid treatment.

Postdischarge Management

Patients who recover from chemical pneumonia generally do not require additional outpatient care, except for adherence to measures to prevent further aspiration episodes.

Unlike chemical pneumonia, anaerobic bacterial infections require prolonged antibiotic treatment; therefore, outpatient treatment is necessary. Patients can be discharged from the hospital after clinical improvement and stability (eg, no fever, no leucocytosis, resolution of hypoxemia) and radiographic improvement (eg, decreased infiltrate or cavity size, no pleural effusion).

In cases with lung abscess, oral antibiotic therapy (ie, clindamycin) is continued for several weeks for treating, although the exact duration of treatment has not been determined.

Prevention of Aspiration Pneumonia

Position patients with altered consciousness in a semirecumbent position with the head of the bed at a 30-45° angle. This reduces the risk of aspiration leading to pneumonia.[13]

For patients with known swallowing dysfunction (eg, dysphagia and/or a poor gag reflex), helpful compensatory techniques to reduce aspiration include a soft diet reducing the bite size, keeping the chin tucked and the head turned, and repeated swallowing. However, although body positioning and changing the consistency of food are reasonable steps, their efficacy has not been proven in controlled trials.[21, 22] In addition, feeding through a nasogastric or gastric tube may be required.

A recent study found that treatment of patients with gastrostomy tubes with mosapride citrate (a gastroprokinetic agent) was associated with a lower risk of aspiration pneumonia in comparison to both placebo and proton pump inhibitor treatment.[23] This therapy holds promise in this specific cohort of patients.

Use of nonparticulate antacids and histamine 2 (H2) blockers to reduce gastric acidity has been a common practice; however, this is very questionable, because gastric acid suppression and consequent loss of the acid barrier to bacteria is associated with a higher rate of pneumonia.

Use antiemetics to reduce lower esophageal sphincter pressure. Before starting enteral tube feeding, confirm the tip location radiographically. Check residual gastric volume regularly. For those on bolus tube, feeding residual should not exceed 150 mL before the next bolus feed.

Avoid oversedating patients.

Prognosis of Aspiration Pneumonia

The prognosis of both chemical pneumonia and bacterial pneumonia is dependent on underlying diseases, complications, and host status.

A retrospective study found the 30-day mortality rate in aspiration pneumonia to be 21% overall and 29.7% in hospital-associated aspiration pneumonia.[8] This mortality range depends on complications of the disease.

In Mendelson's original series in 1946, Mendelson described 61 obstetric patients who aspirated gastric acid during anesthesia, all of whom had a complete clinical recovery within 24-36 hours.[24] In subsequent studies, which have included older sicker patients, chemical pneumonia has a reported mortality rate of 30-62%, because chemical pneumonia often leads to acute respiratory distress syndrome (ARDS). The mortality rate for severe chemical pneumonitis (Mendelson syndrome) can be up to 70%.

If bacterial pneumonia is not treated early, it can lead to development of complications, including lung abscess and bronchopleural fistula in comparison to community-acquired pneumonia. Nosocomial pneumonia is associated with a longer period of hospitalization and increased mortality rates.

The mortality rate for aspiration pneumonitis complicated by empyema is approximately 20%; the mortality for uncomplicated pneumonitis is approximately 5%. An animal model study demonstrated that mice with aspiration pneumonitis were more susceptible to subsequent respiratory infection with certain pathogens.[25]

Special Considerations

The following may be medicolegal pitfalls:

Author

Anand Swaminathan, MD, MPH, Assistant Professor in Emergency Medicine, Assistant Residency Director in Emergency Medicine, Bellevue Hospital Center, New York University School of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Anita B Varkey, MD, Assistant Professor, Department of Medicine, Loyola University Medical Center; Associate Program Director, Internal Medicine Residency; Medical Director, General Internal Medicine Clinic, Loyola Outpatient Center

Disclosure: Nothing to disclose.

Basil Varkey, MD, FCCP, Professor Emeritus, Department of Internal Medicine, Division of Pulmonary and Critical Care, Medical College of Wisconsin; Consulting Pulmonologist, Froedtert Memorial Lutheran Hospital

Disclosure: Nothing to disclose.

Dana A Stearns, MD, Assistant Director of Undergraduate Education, Department of Emergency Medicine, Massachusetts General Hospital; Assistant Professor of Surgery, Harvard Medical School

Disclosure: Nothing to disclose.

Specialty Editors

Laurie Robin Grier, MD, Medical Director of MICU, Professor of Medicine, Emergency Medicine, Anesthesiology and Obstetrics/Gynecology, Fellowship Director for Critical Care Medicine, Section of Pulmonary and Critical Care Medicine, Louisiana State University Health Science Center at Shreveport

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Paul Blackburn, DO, FACOEP, FACEP, Attending Physician, Department of Emergency Medicine, Maricopa Medical Center

Disclosure: Nothing to disclose.

Robert E O'Connor, MD, MPH, Professor and Chair, Department of Emergency Medicine, University of Virginia Health System

Disclosure: Nothing to disclose.

Chief Editor

Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Director, Women's Guild Pulmonary Disease Institute, Professor and Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center, University of California, Los Angeles, David Geffen School of Medicine

Disclosure: Nothing to disclose.

Additional Contributors

Past contributors

Sassan Naderi, MD Staff Physician, Department of Emergency Medicine, North Shore/Long Island Jewish Health System, Albert Einstein College of Medicine

Disclosure: Nothing to disclose.

References

  1. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. Mar 1 2001;344(9):665-71. [View Abstract]
  2. Varkey B, Kutty K. Pulmonary aspiration syndromes. In: Kochar's Concise Textbook of Medicine. Baltimore, Md:. Lippincott Williams & Wilkins;1998:902-906.
  3. Cabre M, Serra-Prat M, Palomera E, Almirall J, Pallares R, Clave P. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing. Jan 2010;39(1):39-45. [View Abstract]
  4. Adnet F, Baud F. Relation between Glasgow Coma Scale and aspiration pneumonia. Lancet. Jul 13 1996;348(9020):123-4. [View Abstract]
  5. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest. Jan 1999;115(1):178-83. [View Abstract]
  6. Mier L, Dreyfuss D, Darchy B, Lanore JJ, Djedaïni K, Weber P, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med. 1993;19(5):279-84. [View Abstract]
  7. Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg. May 1998;227(5):743-51; discussion 751-5. [View Abstract]
  8. Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. J Hosp Med. Feb 2013;8(2):83-90. [View Abstract]
  9. Janssens JP. Pneumonia in the elderly (geriatric) population. Curr Opin Pulm Med. May 2005;11(3):226-30. [View Abstract]
  10. Reza Shariatzadeh M, Huang JQ, Marrie TJ. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc. Feb 2006;54(2):296-302. [View Abstract]
  11. Akritidis N, Gousis C, Dimos G, Paparounas K. Fever, cough, and bilateral lung infiltrates. Achalasia associated with aspiration pneumonia. Chest. Feb 2003;123(2):608-12. [View Abstract]
  12. Marom EM, McAdams HP, Erasmus JJ, Goodman PC. The many faces of pulmonary aspiration. AJR Am J Roentgenol. Jan 1999;172(1):121-8. [View Abstract]
  13. Vadeboncoeur TF, Davis DP, Ochs M, Poste JC, Hoyt DB, Vilke GM. The ability of paramedics to predict aspiration in patients undergoing prehospital rapid sequence intubation. J Emerg Med. Feb 2006;30(2):131-6. [View Abstract]
  14. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. May 1996;153(5):1711-25. [View Abstract]
  15. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. Nov 27 1999;354(9193):1851-8. [View Abstract]
  16. [Guideline] Coffin SE, Klompas M, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. Oct 2008;29 Suppl 1:S31-40. [View Abstract]
  17. [Guideline] Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. Mar 26 2004;53:1-36. [View Abstract]
  18. Moore FA. Treatment of aspiration in intensive care unit patients. JPEN J Parenter Enteral Nutr. Nov-Dec 2002;26(6 Suppl):S69-74; discussion S74. [View Abstract]
  19. Bartlett JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin North Am. Mar 2013;27(1):149-55. [View Abstract]
  20. Wei C, Cheng Z, Zhang L, Yang J. Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit. Am J Infect Control. Mar 22 2013;[View Abstract]
  21. Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc. Jul 2003;51(7):1018-22. [View Abstract]
  22. Logemann JA, Gensler G, Robbins J, et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res. Feb 2008;51(1):173-83. [View Abstract]
  23. Takatori K, Yoshida R, Horai A, et al. Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding. J Gastroenterol. Dec 13 2012;[View Abstract]
  24. Mendelson CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol. 1946;52:191.
  25. van Westerloo DJ, Knapp S, van't Veer C, Buurman WA, de Vos AF, Florquin S. Aspiration pneumonitis primes the host for an exaggerated inflammatory response during pneumonia. Crit Care Med. Aug 2005;33(8):1770-8. [View Abstract]
  26. Kadowaki M, Demura Y, Mizuno S, Uesaka D, Ameshima S, Miyamori I. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest. Apr 2005;127(4):1276-82. [View Abstract]

Aspiration pneumonia in an 84-year-old man in generally good health who had fever and cough. This posteroanterior radiograph demonstrates a left lower lobe opacity.

Chest radiograph of a patient with aspiration pneumonia of the left lung after a benzodiazepine overdose. The patient was probably positioned to the left at the moment of aspiration

Chest radiograph of a patient with aspiration pneumonia of the left lung after a benzodiazepine overdose. The patient was probably positioned to the left at the moment of aspiration

Aspiration pneumonia in an 84-year-old man in generally good health who had fever and cough. This posteroanterior radiograph demonstrates a left lower lobe opacity.

Lateral radiograph in an 84-year-old patient with aspiration pneumonia confirms the location of the abnormality in the left lower lobe.

Chest radiograph of a patient with massive aspiration pneumonia of the right lung.

Aspiration pneumonia in an 84-year-old man in generally good health who had fever and cough. This posteroanterior radiograph demonstrates a left lower lobe opacity.

Lateral radiograph in an 84-year-old patient with aspiration pneumonia confirms the location of the abnormality in the left lower lobe.

Chest radiograph of a patient with aspiration pneumonia of the left lung after a benzodiazepine overdose. The patient was probably positioned to the left at the moment of aspiration

Chest radiograph of a patient with massive aspiration pneumonia of the right lung.